15-oxoprostaglandin 13-reductase

Preferred Label : 15-oxoprostaglandin 13-reductase;

MeSH definition : (5Z)-(15S)-11 alpha-Hydroxy-9,15-dioxoprostanoate:NAD(P) delta(13)-oxidoreductase. An enzyme active in prostaglandin E and F catabolism. It catalyzes the reduction of the double bond at the 13-14 position of the 15-ketoprostaglandins and uses NADPH as cofactor. EC 1.3.1.48.;

MeSH synonym : delta 13 pg reductase; delta 13 15 ketoprostaglandin reductase; delta 13-reductase, 15-ketoprostaglandin; delta 13-15-ketoprostaglandin reductase; delta-13-pg-reductase; delta-13-reductase, prostaglandin; prostaglandin delta 13 reductase; prostaglandin delta-13-reductase; prostaglandin-13,14-reductase; reductase, delta 13-15-ketoprostaglandin; 13-reductase, 15-ketoprostaglandin delta; 13-reductase, 15-oxoprostaglandin; 13-15-ketoprostaglandin reductase, delta; 15 ketoprostaglandin delta 13 reductase; 15-ketoprostaglandin delta 13-reductase; prostaglandin 13,14 reductase; 15 oxoprostaglandin 13 reductase;

Registry Number MeSH : EC 1.3.1.48;

MeSH annotation : DF: OXOPG REDUCTASE;

Is substance : O;

UNII : EC 1.3.1.48;

Details

Origin ID

D011452;

UMLS CUI

C0033553;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- 15-Oxoprostaglandin 13-Reductase [MeSH concept]
Related MeSH Supplementary Concept(s)
- PTGR2 protein, human [MeSH Supplementary Concept]
- PTGR2 protein, mouse [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
UMLS correspondences (same concept)
- 15-oxoprostaglandin 13-reductase (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients